Low-dose IL-2 preferentially expanded CD4+ Treg cells by binding to high affinity IL-2Rα (CD25) and ameliorated clinical manifestation of chronic GVHD (93–95). This evidence concerns the gene IL2RA and chronic graft versus host disease.